Login
AxoGen Inc logo

AxoGen Inc

axogeninc.com

AxoGen Inc (NASDAQ: AXGN) is a medical technology company focused on the surgical repair of peripheral nerves. The filing excerpts provided do not contain sufficient detail to describe AxoGen's revenue model, segment breakdown, customer base, competitive position, geographic footprint, or leadership with source-grounded specificity. The cover page of the 10-K filed 2026-02-24 (accession 000080592826000031) confirms AxoGen as the registrant and a well-known seasoned issuer, but the excerpts truncate before any business description, financial data, or operational detail is disclosed. No further factual claims about the company's products, markets, competitors, or financials can be made from the available filing content.

Financial Snapshot

Revenue
TTM
$251.2M
Gross Margin
TTM
74.63%
Net Income
TTM
-$33.55M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
659.7%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$256.3M
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$1.214M

Stock Price

Loading...
Market Cap: $2.2693 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support